Company Description
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems.
In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions.
The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.
The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.
Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
| Country | United States |
| Founded | 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,227 |
| CEO | Michael Greiner |
Contact Details
Address: 5405 Windward Parkway, Suite 100 South Alpharetta, Georgia 30004 United States | |
| Phone | 844 428 2667 |
| Website | avanos.com |
Stock Details
| Ticker Symbol | AVNS |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001606498 |
| CUSIP Number | 05350V106 |
| ISIN Number | US05350V1061 |
| Employer ID | 46-4987888 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Warren J. Machan | Interim Chief Financial Officer |
| Sigfrido Delgado | Senior Vice President of Operations |
| Mojirade James | Senior Vice President, General Counsel and Corporate Secretary |
| Kerr W. Holbrook | Senior Vice President and Chief Commercial Officer |
| Siobhan Smyth | Vice President and Chief Information Officer |
| Jonathan Turner | Vice President and Chief Ethics and Compliance Officer |
| Katrine Kubis | Vice President of Corporate Communications and Community Relations |
| Scott Galovan | Senior Vice President of Strategy and Corporate Development |
| John W. Cato | Vice President of Global Human Resources |
| Lee Burnes | Senior Vice President of Global Research & Development, Clinical and Medical Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 17, 2025 | ARS | Filing |
| Mar 17, 2025 | 8-K | Current Report |
| Mar 14, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 14, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 6, 2025 | 144 | Filing |
| Feb 26, 2025 | 10-K | Annual Report |
| Feb 26, 2025 | 8-K | Current Report |
| Feb 14, 2025 | SCHEDULE 13G/A | Filing |
| Feb 13, 2025 | SCHEDULE 13G/A | Filing |
| Jan 13, 2025 | 8-K | Current Report |